Ulcerative Colitis and Crohn’s Disease: An Overview
Ulcerative colitis and crohn’s disease are both chronic inflammatory bowel diseases (IBDs) that can cause significant discomfort and disruption to the lives of those affected. While they have some similarities, they also have distinct differences. Ulcerative colitis primarily affects the colon and rectum, leading to inflammation and ulcers in the lining of the large intestine. On the other hand, Crohn’s disease can affect any part of the gastrointestinal tract, from the mouth to the anus, and it can cause inflammation that extends through the entire thickness of the intestinal wall.
Causes of Ulcerative Colitis and Crohn’s Disease
The causes of ulcerative colitis and Crohn’s disease are not fully understood. These IBDs are likely influenced by genetics, environmental factors, and immune system abnormalities. Family history is thought to possibly contribute to both Crohn’s and ulcerative colitis, however, many people who are diagnosed with IBD do not have family members with the disease. Ongoing research aims to uncover the precise mechanisms behind these complex diseases.
Infusion Treatments for Ulcerative Colitis and Crohn’s Disease
At AmeriPharma™ Infusion Center, we offer several Crohn’s infusion treatments, as well as several ulcerative colitis infusion treatments specifically designed to manage the symptoms of ulcerative colitis and Crohn’s disease.
Remicade, Inflectra, Infliximab
These anti-TNF (tumor necrosis factor) inhibitors are effective in treating both ulcerative colitis and Crohn’s disease. By blocking the action of TNF-alpha, a key player in the inflammatory process, these medications can help reduce inflammation and promote healing in the gastrointestinal tract.
A valuable Crohn’s infusion treatment option that also works for ulcerative colitis, Entyvio is an integrin receptor antagonist. By selectively blocking certain white blood cells’ migration to the inflamed gut tissues, Entyvio helps reduce inflammation without suppressing the entirety of the immune system.
Stelara is another biological ulcerative colitis infusion treatment that targets specific proteins involved in the inflammatory response in both ulcerative colitis and Crohn’s disease. By interrupting this inflammatory process, Stelara helps alleviate symptoms and maintain remission in patients.
Although primarily used for multiple sclerosis, Tysabri has also shown efficacy in certain cases of Crohn’s disease. As a Crohn’s infusion treatment, it works by preventing immune cells from reaching and causing inflammation in the gut tissues.
Why Choose AmeriPharma™ Infusion Center?
Expertise in IBD Treatment
Our infusion center is staffed with experienced medical professionals who are well-versed in administering infusion treatments for ulcerative colitis and Crohn’s disease.
Convenient and Comfortable Facilities
AmeriPharma™ provides state-of-the-art facilities that prioritize patient comfort during infusion sessions.
Comprehensive Support Services
We offer comprehensive support services, including educational resources and personalized care plans to help patients effectively manage their ulcerative colitis or Crohn’s disease.
At AmeriPharma™, we understand the importance of timely treatment. Our efficient scheduling system aims to minimize wait times for patients, ensuring they receive their infusion therapies promptly.